DNA RNA and Cells

10 Oct 2008 AVONTEC announces the results of a successful proof of concept within a phase 2a study with its drug candidate AVT-02 UE ointment after topical treatment in patients with mild-to-moderate psoriasis
08 Oct 2008 Moraga Announces Licensing Agreement with Pharmacells, Ltd
07 Oct 2008 MDRNA, Inc. Advances RNAi Pipeline With Selection of Lead Candidate for Hypercholesterolemia Program
05 Oct 2008 AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
29 Sep 2008 Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
24 Sep 2008 Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
23 Sep 2008 iCo Therapeutics Provides Interim Trial Results (Diffuse Diabetic Macular Edema)
22 Sep 2008 ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
21 Sep 2008 Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
18 Sep 2008 AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
15 Sep 2008 Sangamo BioSciences Announces Presentation of Data From Diabetic Neuropathy Clinical Trials
15 Sep 2008 Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
15 Sep 2008 Calando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology
10 Sep 2008 Cell Medica announces treatment of first patient in late stage clinical trial of adoptive cell therapy
10 Sep 2008 Pluristem Successfully Concludes Final Pre-Clinical Safety Studies with PLX-PAD in Preparation for Human Trials
10 Sep 2008 Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis(TM) Personalized Immunotherapy Platform
09 Sep 2008 Oxford BioMedica Announces Promising Interim Phase I/II Results of Prosavin(R) in Parkinson's Disease
08 Sep 2008 Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced Prostate Cancer
07 Sep 2008 OncoMune Publishes Positive Results of OCM-8054
04 Sep 2008 Antisoma starts phase II trial of AS1411 in renal cancer
03 Sep 2008 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
02 Sep 2008 Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
02 Sep 2008 Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
01 Sep 2008 Diamyd Medical's NTDDS Technology Effective Against Diabetes Pain
26 Aug 2008 Novosom AG acquires exclusive license from Isis Pharmaceuticals, Inc. for CD40-targeted antisense inhibitors

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up